Report Detail
Global Afatinib Market Insights, Forecast to 2025
- RnM3168180 |
- 30 May, 2019 |
- Global |
- 113 Pages |
- QYResearch |
- Other
The global Afatinib market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Afatinib market based on company, product type, end user and key regions.
This report studies the global market size of Afatinib in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Afatinib in these regions.
This research report categorizes the global Afatinib market by top players/brands, region, type and end user. This report also studies the global Afatinib market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Boehringer Ingelheim
Hengrui Medicine
Beacon Pharma
Afatinib market size by Type
30mg Tables
40mg Tables
50mg Tables
25mg Tables
20mg Tables
Other
Afatinib market size by Applications
Hospital
Clinic
Drug Center
Other
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Afatinib market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Afatinib market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Afatinib companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Afatinib submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Afatinib are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Afatinib market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Afatinib Product Introduction
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Afatinib Market Size Growth Rate by Type
- 1.4.2 30mg Tables
- 1.4.3 40mg Tables
- 1.4.4 50mg Tables
- 1.4.5 25mg Tables
- 1.4.6 20mg Tables
- 1.4.7 Other
- 1.5 Market by Application
- 1.5.1 Global Afatinib Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Drug Center
- 1.5.5 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Afatinib Market Size
- 2.1.1 Global Afatinib Revenue 2014-2025
- 2.1.2 Global Afatinib Sales 2014-2025
- 2.2 Afatinib Growth Rate by Regions
- 2.2.1 Global Afatinib Sales by Regions
- 2.2.2 Global Afatinib Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Afatinib Sales by Manufacturers
- 3.1.1 Afatinib Sales by Manufacturers
- 3.1.2 Afatinib Sales Market Share by Manufacturers
- 3.2 Afatinib Revenue by Manufacturers
- 3.2.1 Afatinib Revenue by Manufacturers (2014-2019)
- 3.2.2 Afatinib Revenue Share by Manufacturers (2014-2019)
- 3.3 Afatinib Price by Manufacturers
- 3.4 Afatinib Manufacturing Base Distribution, Product Types
- 3.4.1 Afatinib Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Afatinib Product Type
- 3.4.3 Date of International Manufacturers Enter into Afatinib Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
- 4.1 Global Afatinib Sales by Type
- 4.2 Global Afatinib Revenue by Type
- 4.3 Afatinib Price by Type
5 Breakdown Data by Application
- 5.1 Overview
- 5.2 Global Afatinib Breakdown Data by Application
6 North America
- 6.1 North America Afatinib by Country
- 6.1.1 North America Afatinib Sales by Country
- 6.1.2 North America Afatinib Revenue by Country
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Afatinib by Type
- 6.3 North America Afatinib by Application
7 Europe
- 7.1 Europe Afatinib by Country
- 7.1.1 Europe Afatinib Sales by Country
- 7.1.2 Europe Afatinib Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Afatinib by Type
- 7.3 Europe Afatinib by Application
8 Asia Pacific
- 8.1 Asia Pacific Afatinib by Country
- 8.1.1 Asia Pacific Afatinib Sales by Country
- 8.1.2 Asia Pacific Afatinib Revenue by Country
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Afatinib by Type
- 8.3 Asia Pacific Afatinib by Application
9 Central & South America
- 9.1 Central & South America Afatinib by Country
- 9.1.1 Central & South America Afatinib Sales by Country
- 9.1.2 Central & South America Afatinib Revenue by Country
- 9.1.3 Brazil
- 9.1.4 Argentina
- 9.2 Central & South America Afatinib by Type
- 9.3 Central & South America Afatinib by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Afatinib by Country
- 10.1.1 Middle East and Africa Afatinib Sales by Country
- 10.1.2 Middle East and Africa Afatinib Revenue by Country
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Afatinib by Type
- 10.3 Middle East and Africa Afatinib by Application
11 Company Profiles
- 11.1 Boehringer Ingelheim
- 11.1.1 Boehringer Ingelheim Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Boehringer Ingelheim Afatinib Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Boehringer Ingelheim Afatinib Products Offered
- 11.1.5 Boehringer Ingelheim Recent Development
- 11.2 Hengrui Medicine
- 11.2.1 Hengrui Medicine Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Hengrui Medicine Afatinib Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Hengrui Medicine Afatinib Products Offered
- 11.2.5 Hengrui Medicine Recent Development
- 11.3 Beacon Pharma
- 11.3.1 Beacon Pharma Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Beacon Pharma Afatinib Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Beacon Pharma Afatinib Products Offered
- 11.3.5 Beacon Pharma Recent Development
12 Future Forecast
- 12.1 Afatinib Market Forecast by Regions
- 12.1.1 Global Afatinib Sales Forecast by Regions 2019-2025
- 12.1.2 Global Afatinib Revenue Forecast by Regions 2019-2025
- 12.2 Afatinib Market Forecast by Type
- 12.2.1 Global Afatinib Sales Forecast by Type 2019-2025
- 12.2.2 Global Afatinib Revenue Forecast by Type 2019-2025
- 12.3 Afatinib Market Forecast by Application
- 12.4 North America Afatinib Forecast
- 12.5 Europe Afatinib Forecast
- 12.6 Asia Pacific Afatinib Forecast
- 12.7 Central & South America Afatinib Forecast
- 12.8 Middle East and Africa Afatinib Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Afatinib Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Afatinib . Industry analysis & Market Report on Afatinib is a syndicated market report, published as Global Afatinib Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Afatinib market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
